JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


Anesth Analg 1988; 67:775-778
© 1988 International Anesthesia Research Society
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Young, W. L.
Right arrow Articles by Omstein, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Young, W. L.
Right arrow Articles by Omstein, E.

Duration of Action of Neostigmine and Pyridostigmine in the Elderly

William L. Young, MD, Richard S. Matteo, MD, and Eugene Omstein, PhD, MD

Received from the Department of Anesthesiology, College of Physicians and Surgeons, Columbia University, New York, New York.

Abstract

This study was undertaken to assess differences between young and elderly patients with respect to the duration of antagonism of metocurine neuromuscular blockade by neostigmine (NEO) or pyridostigmine (PYR). Patients were given either NEO (seven elderly and ten young) or PYR (seven elderly and eight young) and received nitrous oxide in oxygen (60:40) and 1 MAC halothane. Neuromuscular transmission was assessed by using evoked compound electromyography. Metocurine 0.1 mg/kg was given, followed by a continuous infusion to achieve 90% reduction in baseline single twitch height. After at least 30 minutes, either NEO (0.07 mg/kg) or PYR (0.14 mg/kg) and atropine (0.02 mg/kg) were given IV. After injection of NEO or PYX, the duration of maximal response (DOMR) was recorded. Mean (± SE) ages were 38 ± 5 and 68 ± 2 years in the two groups of patients receiving PYX. In the elderly, PYX significantly prolonged DOMR compared to younger patients (35.3 ± 8.2 vs 14.4 ± 4.2 minutes, respectively). The mean ages in the two groups of patients receiving NEO were 41.5 ± 4 and 72 ± 2 years. The elderly group demonstrated a significant increase in the DOMR compared to younger patients (32 ± 10 vs 11 ± 2 minutes, respectively). It is concluded that, compared to younger patients, the duration of action of NEO and PYR in the aged patient is prolonged.

Key Words: NEUROMUSCULAR RELAXANTS—metocurine • ANTAGONISTS, NEUROMUSCULAR RELAXANTS—neostigmine, pyridostigmine • AGE FACTORS—duration of action of relaxant antagonists







Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 1988 by the International Anesthesia Research Society.